Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
There is a growing body of evidence in the literature regarding the adverse effects of hyperglycemia in critically ill patients. To target and maintain better blood glucose regulation we implemented an insulin protocol with target blood glucose levels between 81-110 mg/dL.
Condition or disease
Critically Ill Patients
Drug: to implement an insulin protocol with target blood glucose levels between 81-110 mg/dL.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
16 Years and older (Child, Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Surgical or medical critically ill patients
An expected ICU-stay of more than 72 hours
Age > 16 years
Need for insulin therapy
Patients must have an arterial line
Patients who did not respond to the inclusion criteria